Is Adverum Biotechnology, Inc (ADVM) stock Doomed to Fail?
Adverum Biotechnologies, Inc. (ADVM) was subject to a 6.49% drop in share price on April 9th, 2021, now sitting at USD$9.08. Given that they are still in the clinical stages, the full potential of their profitability is still being determined. Nevertheless, ADVM management has time and time again assured investors of their focus on and […]
